The news comes after Nice approved the first long-term daily pill for endometriosis in March, known as relugolix combination therapy or Ryeqo. Helen Knight, director of medicines evaluation at Nice, ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS in ...

A new at-home daily pill for endometriosis has been approved for use on the NHS in England. The tablet, called linzagolix but ...

Ryeqo was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) last October based on results from the LIBERTY programme, consisting of two 24-week phase 3 clinical trials.

The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age for whom other treatment options – including medical and surgical ...

Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy after Gedeon Richter's Ryeqo was cleared for NHS use. This morning, NICE recommended ...